Ret Proto-Oncogene anticorps (Extracellular Domain)
Aperçu rapide pour Ret Proto-Oncogene anticorps (Extracellular Domain) (ABIN2744027)
Antigène
Voir toutes Ret Proto-Oncogene (RET) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- Extracellular Domain
-
Purification
- Affinity purified
-
Immunogène
-
Recombinant fragment of human c-Ret extracellular domain expressed in E. coli.
Type of Immunogen: Recombinant protein -
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 1 % BSA, 0.1 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- Ret Proto-Oncogene (RET)
-
Autre désignation
- RET
-
Sujet
-
Name/Gene ID: RET
Subfamily: Cadherin
Family: Protein Kinase
Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9 -
ID gène
- 5979
-
Pathways
- Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Antigène
-